Nutrien (NTR) Misses Q3 EPS by $1.59; Lowers Outlook

Nutrien (NYSE: NTR) reported Q3 EPS of $2.51, $1.59 worse than the analyst estimate of $4.10. Revenue for the quarter came in at $8.19 billion versus the consensus estimate of $8.97 billion.

GUIDANCE:

Nutrien sees FY2022 EPS of $13.25-$14.50, versus the consensus of $16.55.

For earnings history and earnings-related data on Nutrien (NTR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c